交易 Vir Biotechnology VIR

出售
 購買

VirBiotechnology實時圖表

5m 15m 30m 1h 4h 1d 1w

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%)： 開倉 高 低

最新新聞

Frances Wang 2025 Apr 22, 16:00

歐洲央行會降息嗎？利率如何影響債券市場？

Frances Wang 2025 Apr 22, 16:00

關稅新聞：亞洲市場上漲，日元因關稅談判下跌

Frances Wang 2025 Apr 22, 16:00

今日AMD股價：影響AMD股價的因素

Frances Wang 2025 Apr 21, 16:00

今日股市：道瓊斯、標普500和納斯達克因特朗普批評聯邦儲備主席鮑威爾而下跌

Frances Wang 2025 Apr 21, 16:00

亞洲股市指數：恆生指數下跌，日經225指數下滑，印度Sensex上漲

Frances Wang 2025 Apr 21, 16:00

今日金價：XAUUSD超過3,400美元，面對關稅不確定性

Frances Wang 2025 Apr 21, 16:00

今日外匯市場：美元跌至三年低點，USD/CHF接近0.8102

Frances Wang 2025 Apr 20, 16:00

現在值得考慮的股票：Nu股票是一個好選擇嗎？

聯絡方式

點差

0.05

點差(%)

0.8389 %

槓桿

1:10

隔夜利息（買入）

-0.0597 %

隔夜利息（賣出）

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

800771200

流通股份

138064000

收益日期（下一個）

0000-00-00

現金殖利率 

除息日

遠期年股息率

0

遠期年現金殖利率

0

每股盈餘

-3.83

了解有關此金融工具的詳細資訊

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

相關工具

資產
出售
購買
更改(%)：

立即交易

立即交易

立即交易

立即交易
查看所有金融工具
Trustpilot